HopeStage
Back to all studies
CompletedNCT00585702

Antimanic medication and maternal-infant health during bipolarity pregnancy

About this titleRead the official source — NCT00585702
Observational studyAges 18–45United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 45 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2006
Recruitment status
Completed
Enrollment listed in the registry
201
Sponsor
University of Pittsburgh
Sponsor type
University
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT00585702
Official title
Show the full official title

Antimanic Drug Use in Pregnancy

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Pittsburgh

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pittsburgh, a university.

Who was this study for?

Listed age limits: 18 years to 45 years.

Want to explore more studies?

Explore studies